OpenClaw is an AI agent platform developed by Peter Steinberger in November 2025, designed to give AI models the ability to ...
UCB, a global biopharmaceutical company, today announced new data in moderate-to-severe plaque psoriasis (PSO) at the 2026 American Academy of Dermatology (AAD) Annual Meeting in Denver, March 27–31.
Beyond supporting the LKAB contract, the vessels position NORDEN to expand its reach among industrial customers with transport needs in northern regions. The addition of modern, ice-class tonnage ...
ABN AMRO has launched a EUR 250 million share buyback programme starting 27 March 2026 and running until October 2026, aimed at reducing its share capital while maintaining strong capital levels, with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results